DIAGNOS Inc.
DGNOF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.33 | 0.21 | 0.86 | -0.45 |
| FCF Yield | -2.69% | -5.04% | -4.30% | -5.01% |
| EV / EBITDA | -47.99 | -21.34 | -27.65 | -24.37 |
| Quality | ||||
| ROIC | -126.96% | -60.96% | -38.87% | -38.04% |
| Gross Margin | -2,377.64% | -1,919.54% | -1,578.36% | -1,054.57% |
| Cash Conversion Ratio | 0.59 | 0.81 | 0.93 | 0.90 |
| Growth | ||||
| Revenue 3-Year CAGR | -49.19% | -46.65% | -43.30% | -39.30% |
| Free Cash Flow Growth | 8.33% | 27.01% | -13.41% | -100.46% |
| Safety | ||||
| Net Debt / EBITDA | -2.96 | -2.49 | -2.59 | -3.12 |
| Interest Coverage | -13.01 | -8.32 | -8.43 | -7.08 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 724.21 | 675.05 | 695.56 | 292.50 |